热门资讯> 正文

Pliant Therapeutics GAAP每股收益为-0.38美元在线

2026-03-12 04:36

Pliant Therapeutics(PLRX) 0
奥本海默控股(OPY) 0

Pliant Therapeutics press release (PLRX): Q4 GAAP EPS of -$0.38 in-line.
As of December 31, 2025, the Company had cash, cash equivalents and short-term investments of $192.4 million which the Company expects to be sufficient to fund operations into the second half of 2028.

More on Pliant Therapeutics

Pliant Therapeutics, Inc. (PLRX) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript
Pliant Therapeutics: A Reverse Arbitrage Opportunity Driven By A Poison Pill Expiration
Seeking Alpha’s Quant Rating on Pliant Therapeutics
Historical earnings data for Pliant Therapeutics
Financial information for Pliant Therapeutics

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。